The Global Acetonitrile Market is expected to grow from USD 889.48 Million in 2026 to USD 1,160.57 Million by 2035, with a CAGR of 3%.

Growth is supported by demand from pharmaceutical manufacturing, laboratory testing, HPLC applications, and chemical processing.

Sample Report:
https://www.researchreportsworld.com/enquiry/request-sample/501360

#Acetonitrile #ChemicalIndustry #Pharmaceuticals #MarketResearch

Investment in Kazakhstan’s Pharmaceutical Manufacturing More Than Triples in Three Years

https://fed.brid.gy/r/https://timesca.com/investment-in-kazakhstans-pharmaceutical-manufacturing-more-than-triples-in-three-years/

In a bid to curb insurance premium hikes for the working population, Japan has passed legislation to raise co-payments for prescription medications with ingredients and effects similar to over-the-counter drugs. https://www.japantimes.co.jp/news/2026/05/29/japan/science-health/medical-bill-passes-parliament/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #insurance #medicine #pharmaceuticals #pregnancy #diet #health
Japan passes bill to raise co-payments for prescription drugs similar to OTC counterparts

The health ministry plans to require individuals to bear additional costs for some 1,100 over-the-counter-like prescription drugs starting in March 2027.

The Japan Times
Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics
Ozempic and Wegovy, both produced by Novo Nordisk, currently cost hundreds of dollars a month, depending on the dosage dispensed, in some cases more than $450.
#Health #GLP1 #Ozempic
https://globalnews.ca/news/11863331/novo-nordisk-slash-ozempic-price-generics/
Africa: Building Ethiopia's Pharmaceutical Future - From Strong Regulation to Local Production: [World Bank] Ethiopia is transforming from an import-dependent market into a pharmaceutical manufacturing hub. After becoming the 9th African nation to reach WHO Maturity Level 3, local production now exceeds 40% of medicine supply. This WBG feature examines how regulation, the Kilinto Special Economic Zone,… http://newsfeed.facilit8.network/TSlhSm #Ethiopia #Pharmaceuticals #HealthSovereignty #LocalProduction #WHO
Biogen probed by Italy over MS drug competition

Italy probes Biogen over alleged attempts to block Sandoz’s MS biosimilar and limit competition in natalizumab drugs.

𝗚𝗹𝗼𝗯𝗮𝗹 𝗱𝗿𝘂𝗴 𝗽𝗮𝗰𝗸𝗮𝗴𝗶𝗻𝗴 𝗱𝗲𝗺𝗮𝗻𝗱 𝗶𝘀 𝗿𝗶𝘀𝗶𝗻𝗴 𝗮𝘀 𝗶𝗻𝗷𝗲𝗰𝘁𝗮𝗯𝗹𝗲 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗯𝗲𝗰𝗼𝗺𝗲 𝗺𝗼𝗿𝗲 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹!
The 𝗚𝗹𝗼𝗯𝗮𝗹 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗚𝗹𝗮𝘀𝘀 𝗩𝗶𝗮𝗹𝘀 𝗮𝗻𝗱 𝗔𝗺𝗽𝗼𝘂𝗹𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗶𝘀 𝘃𝗮𝗹𝘂𝗲𝗱 𝗮𝘁 𝗨𝗦𝗗 𝟭𝟬 𝗯𝗶𝗹𝗹𝗶𝗼𝗻, supported by biologics, biosimilars, vaccines, and stronger safety regulations.
𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://www.kenresearch.com/global-pharmaceutical-glass-vials-and-ampoules-market?utm_source=Social+sharing+&utm_medium=Mastodon&utm_campaign=Aniket
#Pharmaceuticals #GlassPackaging #Biologics
Global Pharma Vials Ampoules Market |2019-2030| Ken Research

Global pharmaceutical glass vials and ampoules market valued at USD 10 billion, driven by demand for injectable drugs, biologics, and vaccination programs, with growth from advancements in glass tech.

𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗶𝗻𝗴𝗿𝗲𝗱𝗶𝗲𝗻𝘁 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗼𝗽𝗲𝗻𝗶𝗻𝗴 𝗻𝗲𝘄 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝗔𝘀𝗶𝗮 𝗣𝗮𝗰𝗶𝗳𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗺𝗮𝗿𝗸𝗲𝘁𝘀!
The 𝗔𝘀𝗶𝗮 𝗣𝗮𝗰𝗶𝗳𝗶𝗰 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗚𝗿𝗮𝗱𝗲 𝗥𝗶𝗰𝗲 𝗦𝘁𝗮𝗿𝗰𝗵 𝗠𝗮𝗿𝗸𝗲𝘁 is expanding due to rising demand for clean label excipients, drug formulation advancements, and growth in nutraceutical applications.
𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://www.kenresearch.com/industry-reports/asia-pacific-pharmaceutical-grade-rice-starch-market?utm_source=Social+sharing+&utm_medium=Mastodon&utm_campaign=Aniket
#Pharmaceuticals #Healthcare #AsiaPacific #Nutraceuticals
Asia Pacific Pharmaceutical Grade Rice Starch Market, Share, Major Players and Outlook to 2030

Unlock data-backed intelligence on Asia Pacific Pharmaceutical Grade Rice Starch Market size at USD 500 million in 2023, showcasing industry growth driven by key players and strategic insights.